# \[e-drug\] Community revolving drug schemes

**URL:** <https://talk.edrugplus.org/t/e-drug-community-revolving-drug-schemes/16085>\
**Category:** e-drug\
**Created:** [February 11, 2003, 8:11am UTC](https://talk.edrugplus.org/t/e-drug-community-revolving-drug-schemes/16085 "2003-02-11T08:11:52Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Vera\_Lucia\_Luiza](https://avatars.discourse-cdn.com/v4/letter/v/b3f665/32.png) [@Vera\_Lucia\_Luiza](https://talk.edrugplus.org/u/Vera_Lucia_Luiza)\
**Post date:** [February 11, 2003, 8:11am UTC](https://talk.edrugplus.org/t/e-drug-community-revolving-drug-schemes/16085/1 "2003-02-11T08:11:52Z")

</div>

E-drug: Community revolving drug schemes  
---------------------------------------------

Please

I would like to know about national experiences with community revolving  
drug schemes.

Thank you

Vera Lucia Luiza

Nucleus of Pharmaceutical Policies (NAF); National School of Public Health  
(ENSP)  
NAF / ENSP / Fiocruz  
Av Brasil, 4036/916, Manguinhos  
21040 361 - Rio de Janeiro RJ  
++55 21 2260-1790 and 3882-9067; Fax: 2260-1652  
Vera Lucia Luiza \<vera@ensp.fiocruz.br\>

[Coincidentally, a message from Gamal Khalafalla Mohammed about a  
study in Sudan has just been posted. He is offering to share his  
study as a pdf document - see previous message. It is worth  
consulting the archives at [http://www.essentialdrugs.org/edrug](http://www.essentialdrugs.org/edrug) to  
see previous discussions about this subject as well, BS].  
--  
To send a message to E-Drug, write to: e-drug@usa.healthnet.org  
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org  
in the body of the message type: subscribe e-drug OR unsubscribe e-drug  
To contact a person, send a message to: e-drug-help@usa.healthnet.org  
Information and archives: [http://www.essentialdrugs.org/edrug](http://www.essentialdrugs.org/edrug)
